 Eidos Therapeutics Inc NASDAQ:EIDX was the target of a significant decline in short interest in the month of March. As of March 13th, there was short interest totalling 2,093,600 shares, a decline of 5.7 from the February 27th total of 2,220,000 shares. Currently, 24.3 of the shares of the company are sold short. Based on ... 